Reporte zur Charge U06M20A

Symptomtext

red bump; headache; Red; little bruise; swelled; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U06M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE BRUISING (little bruise) and VACCINATION SITE SWELLING (swelled). On 21-Feb-2021, the patient experienced VACCINATION SITE MASS (red bump), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOCAINE HYDROCHLORIDE (NEOSPORIN + BURN RELIEF) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided by reporter.